Physician profile
Khalid Shafiq
NPI 1174527766
$1,984.37
in general payments reported to CMS, 2019-2025
9 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $375 · 2021: $124 · 2022: $355 · 2023: $134 · 2024: $151 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $667.78 | 2019-2023 | |
| Biotronik INC. | $504.61 | 2022-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Pulsar-18 T3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $457.74 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $150.29 | 2019-2022 | |
| Abbott Laboratories | $102.80 | 2019-2023 | Mitraclip |
| Opko Pharmaceuticals, LLC | $41.61 | 2020 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $33.36 | 2019 | |
| Abiomed | $13.73 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Shafiq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.